Medtronic plc (MDT) Financials
Key financial figures for Medtronic plc (Q1 2027).
Medtronic posted Q1 FY2027 revenue of $9.76 billion, up 13.7% both as reported and organically, and raised full-year organic growth and non-GAAP EPS guidance. Revenue reached $9.756 billion, up 13.7% as reported and 13.7% organic, aided by an extra fiscal week that added roughly $570 million to the growth comparison. GAAP diluted EPS was $1.14 (up 40.7% year over year) and non-GAAP diluted EPS was $1.45 (up 15.1%), which management said came in ahead of its own guidance. All four segments grew double digits on a reported basis: Cardiovascular $3.927B (+19.5%), Neuroscience $2.678B (+10.3%), Medical Surgical $2.279B (+10.0%), and Diabetes $843M (+16.9%). On the outlook: Raised FY2027 guidance to organic revenue growth of 7.25%-7.75% (from 6.75%-7.25%) and non-GAAP diluted EPS of $5.94-$6.00 (from $5.90-$6.00). Figures are for Q1 FY2027, as Medtronic plc reported them.
- Revenue
- $9.8B
- Net Income
- $1.5B
- EPS
- $1.15
- Total Assets
- $93.3B
- Operating Cash Flow
- $1.8B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q1 FY2027 | $9.8B | $1.5B | $1.14 | 18.08% | $1.3B |
| Q4 FY2026 | $9.8B | $1.2B | $0.96 | 15.95% | $2.1B |
| Q3 FY2026 | $9.0B | $1.1B | $0.89 | 19.66% | $2.3B |
| Q2 FY2026 | $9.0B | $1.4B | $1.07 | 18.8% | $457M |
| Q1 FY2026 | $8.6B | $1.0B | $0.81 | 16.85% | $584M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $36.4B | $4.8B | $3.73 | 17.78% | $5.4B |
| FY2025 | $33.5B | $4.7B | $3.61 | 17.76% | $5.2B |
| FY2024 | $32.4B | $3.7B | $2.76 | 15.89% | $5.2B |
Frequently asked questions
What was Medtronic plc's revenue last quarter?
Medtronic plc reported revenue of $9.76 billion for Q1 FY2027, up 13.7% from the same period a year earlier.
Is Medtronic plc profitable?
Yes. Medtronic plc reported net income of $1.47 billion for Q1 FY2027, a net margin of 15.07% on revenue.
How has Medtronic plc's margin trended?
Operating margin was 18.08% in Q1 FY2027, compared with 16.85% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Medtronic plc generate?
Medtronic plc generated free cash flow of $1.29 billion in Q1 FY2027, after capital expenditure.
Full income statement, balance sheet and cash flow for Medtronic plc on SentiSense, with up to forty quarters and twenty fiscal years of history.